Search the Newsreel

Surrozen Inc (SRZN) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Surrozen Inc (SRZN), detailing its volatility, financial risk, and investment risk. It highlights the company's current risk assessment score of 2.53, ranking it among its industry peers, and notes its beta value of 0.52. The report also …

Surrozen, Inc. Revenue Breakdown – NASDAQ:SRZN

Surrozen, Inc. (NASDAQ: SRZN) generated $3.48 million USD in revenue last year, primarily from its Research Service Revenue - Related Party segment. This segment matched the total company revenue, indicating its sole contribution to the company's earnings. The United States was the exclusive geographic …

CURRENC Group Inc (CURR) Financial Health: Profitability & Balance Sheet Analysis

CURRENC Group Inc (CURR) has a robust financial status with a score of 7.48, ranking 36 out of 76 in the Financial Technology & Infrastructure industry. Despite this, its latest quarterly revenue decreased by 21.81% year-over-year, and its net profit saw a 56.57% year-over-year …

Pacific Current Group Ltd Revenue Breakdown – ASX:PAC

Why Currys (LSE:CURY) Is Being Watched In The UK Consumer Share Debate

Surrozen Inc (SRZN) Valuation: PE, PB & Fair Value Analysis

The article provides a valuation analysis for Surrozen Inc (SRZN), noting its current valuation score is 8.29, ranking 150 out of 386 in its industry. It highlights the company's P/E ratio of -0.54 and mentions that relevant data for P/B, P/S, and P/CF ratios …

CURRENC Group Inc (CURR) Dividends & Stock Splits: Historical Payouts and Event Timeline

The article provides an overview of CURRENC Group Inc (CURR) stock, focusing on its dividend and stock split history. It indicates that the company has distributed $0.00 USD in dividends over the past five years. The page displays current stock information, including the stock …

CURRENC Group Inc (CURR) - Tradingkey Stock Score & Comprehensive Stock Analysis

This article provides a comprehensive stock analysis and TradingKey Stock Score for CURRENC Group Inc (CURR). It highlights the company's relatively healthy fundamentals, significant growth potential, and high institutional ownership. Despite strong market performance, the stock is currently trading sideways between support and resistance, …

SRZN|Surrozen Inc|Price:19.660|Chg%:-0.070

This article provides a comprehensive stock analysis of Surrozen Inc (SRZN), highlighting its "fairly valued" status and strong fundamentals despite recent market performance. The company, a biotechnology firm focused on the Wnt pathway, shows high institutional ownership and analyst ratings predominantly as "Buy." It …

Surrozen Inc (SRZN) Cash Flow

This article provides a detailed overview of Surrozen Inc's (SRZN) cash flow statement, including quarterly and annual figures for operating, investing, and financing activities. It presents financial data such as net income, capital expenditures, and free cash flow over several fiscal quarters and years. …

CURRENC Group Inc (CURR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a brief overview of CURRENC Group Inc (CURR) focusing on its revenue breakdown by region. As of FY2023, the company reported total revenue with Malaysia contributing 59.35% ($27.56M), Indonesia 31.24% ($14.50M), and Hong Kong 9.41% ($4.37M). The article also notes that …

Aurrigo International PLC Revenue Breakdown – LSE:AURR

CURRENC Group Inc (CURR) Income Statement

This article presents the quarterly and annual income statements for CURRENC Group Inc (CURR), providing detailed financial performance data from FY2022Q1 to FY2025Q4. It includes key metrics such as total revenue, cost of revenue, operating expenses, operating profit, net income, and earnings per share, …

CURR|CURRENC Group Inc|Price:3.240|Chg%:-0.100

This article provides a detailed financial overview of CURRENC Group Inc (CURR), including its stock price, market capitalization, and key financial statements such as the income statement, balance sheet, and cash flow statement. It highlights the company's earnings date, EPS, revenue, and analyst ratings, …

CURRENC Group Inc (CURR) Shareholder Structure: Major Shareholders & Institutional Holdings

This article provides a detailed breakdown of CURRENC Group Inc's (CURR) shareholder structure, including major shareholders and institutional holdings. It lists the proportion of shares held by top individual and corporate investors, as well as an overview of institutional shareholding trends over several quarters. …

CURRENC Group Inc - Detailed Introduction, Company Background, Business Scope, Financial Data, and Market Performance

This article provides a detailed profile of CURRENC Group Inc (CURR), a Singapore-based investment holding company specializing in fintech and digital remittance services. It outlines the company's business scope, including remittance services through Tranglo and airtime sales through Tranglo and WalletKu, and lists key …

Surrozen Inc (SRZN) Income Statement

TCG Crossover GP II sells $6.9 million in Surrozen shares

TCG Crossover GP II, a significant shareholder and director in Surrozen, Inc. (NASDAQ:SRZN), sold 325,000 shares of the company's common stock for approximately $6.9 million on July 22, 2026. This sale, executed at $21.25 per share, followed the reporting persons disgorging short-swing profits as …

Surrozen (SRZN): TCG Crossover funds, Chen Yu disclose 9.9% stake

An amended ownership report for Surrozen, Inc. (SRZN) filed by investment entities TCG Crossover and Chen Yu shows that Chen Yu beneficially owns 1,148,101 shares, representing 9.9% of the common stock. TCG Crossover Fund II, L.P. and TCG Crossover GP II, LLC each report …

Form 4 Surrozen Inc For: 24 July By Investing.com

This article reports on a Form 4 filing for Surrozen Inc. on July 24, indicating insider trading activity. The stock symbol SRZN is noted with a -6.76% change. The content primarily lists market data and unrelated news, with the Form 4 information being brief.

Currenc Group Inc. (CURR) Stock Price | Live Quotes & Charts | NASDAQ

This page provides live quotes and charts for Currenc Group Inc. (CURR) on NASDAQ, showing its current stock price of $3.34 with a recent drop of $0.10 (-2.99%). It notes the absence of analyst ratings or earnings information for the company. The page is …

CURRENC Group Inc (CURR) Valuation: PE, PB & Fair Value Analysis

The article provides a valuation analysis for CURRENC Group Inc (CURR), noting its current valuation score of 9.67 and ranking within the Financial Technology industry. It highlights the company's negative P/E ratio and mentions that relevant data for P/B, P/S, and P/CF ratios have …

CURRENC Group Inc (CURR) Institutional Confidence

This article provides details on the institutional confidence for CURRENC Group Inc (CURR) as of July 24, 2026. It highlights the institutional shareholdings and recent changes in those holdings for various entities and individuals, with certain investors increasing their stake and others decreasing theirs. …

SRZN|Surrozen Inc|Price:21.170|Chg%:-0.550

Surrozen Inc (SRZN) is a biotechnology company developing drug candidates to modulate the Wnt pathway, with a focus on ophthalmology. The company shows strong fundamentals, high growth potential, and institutional buying, despite a recent sideway trading pattern. Analysts have an average "Buy" rating with …

Understanding Momentum Shifts in (SRZN)

This article provides an AI-generated analysis of Surrozen Inc. (NASDAQ: SRZN), highlighting shifting sentiment from positive near-term to potential mid-term weakness within a long-term strong outlook. It presents three institutional trading strategies tailored for different risk profiles, including position trading, momentum breakout, and risk …

Surrozen Highlights Wnt Retina Pipeline, SZN-8141 IND Timeline at H.C. Wainwright

Surrozen highlighted its Wnt-based retina strategy at H.C. Wainwright's conference, emphasizing the potential of its Frizzled-4 signaling therapies for retinal vascular diseases. The company's lead preclinical program, SZN-8141, combines Wnt agonism and VEGF inhibition, showing promising synergy in preclinical models and targeting an IND …

Surrozen's Insider Selling: A $7 Million Red Flag Amidst Biotech Optimism

A $6.9 million insider stock sale by TCG Crossover GP II, LLC, a 10% owner of Surrozen (NASDAQ: SRZN), on July 22, 2026, has raised concerns despite being compliance-driven due to "short-swing profits." This transaction challenges prior narratives of strong institutional confidence in the …

Atturra Reports FY26 Earnings in Line with Guidance as $20–25 Million Goodwill Impairment Weighs on Government Consulting Business

Murray Cod Australia (ASX: MCA) Slides Toward Multi-Year Lows — Can a Low Valuation Support a Rebound?

Atturra (ASX: ATA): Why Did the IT Services Stock Outperform the Technology Sector?

Surrozen Inc. (SRZN) Gains 3.75% as Shares Approach Key Resistance at $24.14 - PCR Spike

Pacific Current Group (ASX:PAC) Falls 2.18%: Key Trends Investors Should Watch

Surrozen to Present at Upcoming Healthcare Investor Conference

Surrozen, Inc. announced that its management will present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference on July 22, 2026. Interested parties can access an audio webcast of the fireside chat, which will be available on Surrozen's investor relations website. The company is …

SRZN Q1 2026 Earnings: Wider-than-Expected Loss Amid Clinical Progress - Next Quarter Guidance

Surrozen to present at H.C. Wainwright Ophthalmology Conference on July 22, 2026

Surrozen, a biotech company specializing in eye disease therapies, will present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference on July 22, 2026. The presentation will feature a fireside chat on their Wnt signaling-based therapeutics for sight-threatening ophthalmic conditions. This event underscores Surrozen's …

Pacific Current Cancels Shares Following On-Market Buy-Back